Research Output per year
Fingerprint Dive into the research topics where Massimo Colombo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 48 Similar Profiles
Hepatocellular Carcinoma
Medicine & Life Sciences
Hepacivirus
Medicine & Life Sciences
Fibrosis
Medicine & Life Sciences
Chronic Hepatitis C
Medicine & Life Sciences
Hepatitis C
Medicine & Life Sciences
Interferons
Medicine & Life Sciences
Ribavirin
Medicine & Life Sciences
Liver
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1972 2019
Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance
Iavarone, M., Viganò, M., Piazza, N., Occhipinti, V., Sangiovanni, A., Maggioni, M., D'Ambrosio, G., Forzenigo, L. V., Motta, F., Lampertico, P., Rumi, M. G. & Colombo, M., Mar 1 2019, In : Annals of Hepatology. 18, 2, p. 318-324 7 p.Research output: Contribution to journal › Article
Open Access
Hepatocellular Carcinoma
Fine Needle Biopsy
Liver
Fibrosis
Magnetic Resonance Spectroscopy
3
Citations
(Scopus)
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial
Merle, P., Blanc, J. F., Phelip, J. M., Pelletier, G., Bronowicki, J. P., Touchefeu, Y., Pageaux, G., Gerolami, R., Habersetzer, F., Nguyen-Khac, E., Casadei-Gardini, A., Borbath, I., Tran, A., Wege, H., Saad, A. S., Colombo, M., Abergel, A., Richou, C., Waked, I., Yee, N. S. & 30 others, , Jun 1 2019, In : The Lancet Gastroenterology and Hepatology. 4, 6, p. 454-465 12 p.Research output: Contribution to journal › Article
Treatment Failure
Nanoparticles
Doxorubicin
Hepatocellular Carcinoma
Randomized Controlled Trials
2
Citations
(Scopus)
Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection
Degasperi, E., D'Ambrosio, R., Iavarone, M., Sangiovanni, A., Aghemo, A., Soffredini, R., Borghi, M., Lunghi, G., Colombo, M. & Lampertico, P., May 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 6, p. 1183-1191.e7Research output: Contribution to journal › Article
Virus Diseases
Hepacivirus
Antiviral Agents
Hepatocellular Carcinoma
Fibrosis
Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapy
Loglio, A., Iavarone, M., Viganò, M., Orenti, A., Facchetti, F., Cortinovis, I., Lunghi, G., Ceriotti, F., Occhipinti, V., Rumi, M., Sangiovanni, A., Colombo, M. & Lampertico, P., Jan 1 2019, In : Liver International. 39, 10, p. 1964-1974Research output: Contribution to journal › Article
alpha-Fetoproteins
Hepatitis B virus
Hepatocellular Carcinoma
Serum
Therapeutics
7
Citations
(Scopus)
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals
Lleo, A., Aglitti, A., Aghemo, A., Maisonneuve, P., Bruno, S., Persico, M., Rendina, M., Ciancio, A., Lampertico, P., Brunetto, M. R., Di Marco, V., Zuin, M., Andreone, P., Villa, E., Troshina, G., Degasperi, E., Coco, B., Calvaruso, V., Giorgini, A. M., Conti, F. & 5 others, , 2019, In : Digestive and Liver Disease. 51, 2, p. 310-317Research output: Contribution to journal › Article
Antiviral Agents
Hepatocellular Carcinoma
Recurrence
alpha-Fetoproteins
Portal Hypertension